Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001857595 | SCV002246991 | pathogenic | not provided | 2021-02-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asp243Glyfs*12) in the AGXT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AGXT are known to be pathogenic (PMID: 19479957). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with hyperoxaluria (PMID: 17495019). ClinVar contains an entry for this variant (Variation ID: 204197). For these reasons, this variant has been classified as Pathogenic. |
Clinical Biochemistry Laboratory, |
RCV000186404 | SCV000239754 | pathogenic | Primary hyperoxaluria, type I | 2014-11-27 | no assertion criteria provided | research |